(0.59%) 5 076.50 points
(0.34%) 38 199 points
(0.83%) 17 582 points
(0.68%) $79.54
(2.28%) $1.976
(-0.16%) $2 307.40
(-1.21%) $26.43
(0.27%) $957.50
(0.16%) $0.934
(0.52%) $11.09
(0.07%) $0.799
(-1.52%) $91.84
-1.45% $ 0.340
Live Chart Being Loaded With Signals
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally...
Stats | |
---|---|
Volumen de hoy | 1 500.00 |
Volumen promedio | 76 504.00 |
Capitalización de mercado | 46.43M |
EPS | $0 ( 2024-02-14 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-08 |
Last Dividend | $0.275 ( 1999-09-02 ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.33 |
ATR14 | $0 (0.00%) |
Microbix Biosystems Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Microbix Biosystems Inc Finanzas
Annual | 2023 |
Ingresos: | $16.51M |
Beneficio Bruto: | $7.48M (45.30 %) |
EPS: | $-0.000300 |
FY | 2023 |
Ingresos: | $16.51M |
Beneficio Bruto: | $7.48M (45.30 %) |
EPS: | $-0.000300 |
FY | 2022 |
Ingresos: | $19.08M |
Beneficio Bruto: | $11.12M (58.32 %) |
EPS: | $0.0132 |
FY | 2021 |
Ingresos: | $18.59M |
Beneficio Bruto: | $11.04M (59.40 %) |
EPS: | $0.0280 |
Financial Reports:
No articles found.
Microbix Biosystems Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.275 | 1999-09-02 |
Last Dividend | $0.275 | 1999-09-02 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.275 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.33 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.34 | |
Div. Directional Score | 7.72 | -- |
Year | Amount | Yield |
---|---|---|
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
XDUH.TO | Dividend Knight | 2023-08-25 | Monthly | 7 | 1.47% | |
PLC.TO | Dividend Knight | 2023-06-29 | Bi-Monthly | 14 | 0.77% | |
EXE.TO | Dividend King | 2023-09-28 | Monthly | 13 | 4.13% | |
ZRE.TO | Dividend Knight | 2023-08-29 | Monthly | 15 | 2.60% | |
TLF.TO | Dividend King | 2023-08-30 | Monthly | 13 | 3.15% | |
L-PB.TO | Dividend King | 2023-09-14 | Quarterly | 10 | 3.24% | |
CMAR.TO | Dividend Knight | 2023-09-22 | Monthly | 5 | 2.05% | |
XLB.TO | Dividend Knight | 2023-08-25 | Monthly | 19 | 1.89% | |
PZA.TO | Dividend Royal | 2023-09-28 | Monthly | 20 | 4.10% | |
FM.TO | Dividend Junior | 2023-08-25 | Semi-Annually | 20 | 0.32% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.157 | 1.500 | 6.87 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0957 | 1.200 | 6.81 | 8.17 | [0 - 0.3] |
returnOnEquityTTM | 0.144 | 1.500 | 9.52 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 8.53 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 5.99 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.60 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.164 | -1.500 | 7.27 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 5.12 | 1.000 | 9.21 | 9.21 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00702 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.000274 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.221 | -1.500 | 9.12 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.558 | 1.000 | 4.03 | 4.03 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.200 | 1.000 | 8.01 | 8.01 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.159 | 1.000 | -0.226 | -0.226 | [0.2 - 2] |
assetTurnoverTTM | 0.611 | 0.800 | 9.26 | 7.41 | [0.5 - 2] |
Total Score | 12.10 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.22 | 1.000 | 8.77 | 0 | [1 - 100] |
returnOnEquityTTM | 0.144 | 2.50 | 9.69 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.000274 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00702 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.107 | 1.500 | -2.62 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0427 | 1.000 | -1.431 | 0 | [0.1 - 0.5] |
Total Score | 3.34 |
Microbix Biosystems Inc
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico